| Literature DB >> 21887800 |
Chang-Ji Zheng1, Sheng-Ming Jiang, Zhen-Hua Chen, Bai-Jun Ye, Hu-Ri Piao.
Abstract
36 Novel heterocyclic chalcone derivatives were synthesized and tested for their anti-bacterial activity. Some compounds presented good anti-microbial activities against Gram-positive bacteria (including the multidrug-resistant clinical isolates). This class of compounds presented high potency against Streptococcus mutans, among which the derivatives F2 with an MIC of 2 µg/mL was as active as the standard drug (norfloxacin) and less active than oxacillin. All the compounds did not inhibit the growth of Gram-negative bacteria (Escherichia coli CCARM 1924 or Escherichia coli CCARM 1356) at 64 µg/mL.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21887800 DOI: 10.1002/ardp.201100005
Source DB: PubMed Journal: Arch Pharm (Weinheim) ISSN: 0365-6233 Impact factor: 3.751